Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-7706
Chem Pharm Bull (Tokyo) 2002 Jan 01;501:31-9. doi: 10.1248/cpb.50.31.
Show Gene links Show Anatomy links

Synthesis of N1-phenethyl substituted indole derivatives as new melatoninergic agonists and antagonists.

Tsotinis A , Vlachou M , Eleutheriades A , Prinea E , Ebreo D , The MT , Sugden D .


???displayArticle.abstract???
The potency of new indolic N1-phenethyl substituted melatoninergic ligands with and without methyl groups in the alpha and beta position of the alkanamidoethyl side chain was examined using the pigment aggregation response in a clonal line of Xenopus laevis melanophores. The non 5-OMe substituted compounds, 8a--e, are all weak antagonists while introduction of the 5-OMe group, 9a--e, increases both agonist and antagonist activity except for 9c (R=C3H7), which is only an agonist and 9e (R=c-C4H7), which is only an antagonist. Introduction of an alpha-methyl group into the 5-OMe derivatives, 14a-e, reduces the agonist potency while introduction of a beta-methyl group has only a small effect on either the agonist or antagonist potency. Double beta-methyl substitution of the 5-OMe derivatives, 20a--e, generally increases the agonist potential (20c, R=C3H7 is the most potent agonist of the compounds described) and decreases the antagonist potency, except for 20a (R=CH3), which is the most potent antagonist of this series of compounds.

???displayArticle.pubmedLink??? 11824582
???displayArticle.link??? Chem Pharm Bull (Tokyo)